Shared Flashcard Set

Details

GI/Pulmonary EXAM 2 - Lubsch
GI/Pulmonary EXAM 2 - Lubsch Acute Asthma
36
Pharmacology
Graduate
04/04/2011

Additional Pharmacology Flashcards

 


 

Cards

Term
acute or subacute episodes of progressively worsening:
shortness of breath
cough
wheezing
chest tightness

progressively worsening lung function documented by decrease in expiratory airflow:
FEV1
PEF

Objective measures more reliably indicate the severity of an exacerbation than does the severity of symptoms, however may not be attainable
Definition
definition of an asthma exacerbation
Term
asthma attack prevalence:
greater with females
greater with Puerto Ricans and American Indians
greater in children aged 0-17 years

asthma ED visits:
similar between males and females
greater with AA
greater with children aged 0-17

asthma hospitalizations:
greater with females
greater with AA
greater with children aged 0-17 years
Definition
epidemiology trends of asthma attack prevalence, asthma ED visits, asthma hospitalizations
Term
none: any person with asthma is at an increased risk or mortality
Definition
which asthma classification (severe, moderate, mild) is at greatest risk for mortality?
Term
ASTHMA HISTORY
history of severe exacerbations (ICU admission/intubation)
>/= 2 hospitalizations in previous year
> 3 ER visits in previous year
using > 2 canisters of SABA per month
poor understanding of asthma symptoms/severity

SOCIAL HISTORY
low socioeconomic status
inner-city residence
illicit drug use
major psychosocial problems

COMORBIDITIES
cardiovascular disease
other chronic lung disease
chronic psychiatric disease
Definition
risk factors for increased asthma mortality
Term
[image]

Early Asthmatic Response:
related to the release of mast cell mediators and macrophages
mediators include: histamine, prostaglandins, leukotrienes, platelet activating factor
immediate effects on bronchial smooth muscle leads to bronchospasm
begins in minutes and lasts about 2 hours
PRIMARY DISORDER IS BRONCHOCONSTRICTION

Late Asthmatic Response:
caused by an increase in: inflammatory mediators, eosinophils, CD4+ T cells, neutrophils, macrophages
T-cell activation leads to release of Th2 cells
begins 6-9 hours after an exposure and takes hours to resolve
PRIMARY DISORDER IS INFLAMMATION

MAY SEE BIMODAL PHASE OF SYMPTOMS
DROP IN FEV1 TWICE IN AN ASTHMA ATTACK
Definition
early asthmatic response and late asthmatic response
Term
EAT

E = environment

A = adherence

T = technique
Definition
what 3 things should always be assessed before initiating treatment for an acute asthma attack?
Term
MILD

signs and symptoms:
dyspnea only with activity (assess tachypnea in young children)
breathlessness while walking
talks in sentences
respiratory rate increased
usually no use of accessory muscles
moderate wheezing, often only end expiratory
pulse < 100
PCO2 < 42
SaO2 > 95%

initial PEF or FEV1:
PEF >/= 70% predicted or personal best
Definition
signs and symptoms and initial PEF or FEV1 of a mild acute asthma exacerbation
Term
usually cared for at home

prompt relief with inhaled SABA

possible short course of oral systemic corticosteroids
Definition
clinical course of a mild asthma exacerbation
Term
MODERATE

signs and symptoms:
dyspnea interferes with or limits usual activity
breathlessness while at rest (infant - softer, shorter cry, difficulty feeding)
talks in phrases
respiratory rate increased
commonly use of accessory muscles
wheeze is loud throughout exhalation
pulse 100-120
PCO2 < 42
SaO2 90-95%

initial PEF or FEV1:
PEF 40-69% predicted or personal best
Definition
signs and symptoms and initial PEF or FEV1 for a moderate asthma exacerbation
Term
usually requires office or ED visit

relief from frequent inhaled SABA

oral systemic corticosteroids

some symptoms last for 1-2 days after treatment is begun
Definition
clinical course for a moderate asthma exacerbatiion
Term
SEVERE

signs and symptoms:
dyspnea at rest, interferes with conversation
breathlessness while at rest (infant - stops feeding)
talks in words
respiratory rate often DECREASED
usually use of accessory muscles
wheeze usually loud throughout inhalation and exhalation
pulse > 120
PCO2 > 42, possible respiratory failure
SaO2 < 90%

initial PEF or FEV1:
PEF < 40% predicted or personal best
Definition
signs and symptoms and initial PEF or FEV1 for a severe asthma exacerbation
Term
usually requires ED visit and likely hospitalization

partial relief from frequent inhaled SABA

oral systemic corticosteroids

some symptoms last for > 3 days after treatment is begun

adjunctive therapies are helpful
Definition
clinical course for a severe asthma exacerbation
Term
LIFE THREATENING

signs and symptoms:
too dyspneic to speak, perspiring
drowsy or confused
ABSENCE OF WHEEZE
BRADYCARDIA
PCO2 > 42, possible respiratory failure
SaO2 < 90%

initial PEF or FEV1:
PEF < 25% predicted or personal best
Definition
signs and symptoms and initial PEF or FEV1 for a life threatening asthma exacerbation
Term
requires ED/hospitalization; possible ICU

minimal or no relief from frequent inhaled SABA

IV corticosteroids

adjunctive therapies are helpful
Definition
clinical course for a life threatening asthma exacerbation
Term
correct hypoxemia
O2 SATUREATION SHOULD BE ABOVE 90%

reverse airway obstruction:
repetitive or continuous SABA (to counteract early asthma response - bronchoconstriction)
systemic corticosteroids in moderate-severe exacerbations or failed response to SABA (helps with obstruction and inflammation)

reduce the potential for relapse/recurrence by intensifying therapy
Definition
treatment goals of an acute asthma exacerbation
Term
oral corticosteroids - prolong duration

ICS - double the dose for one week
doubling the ICS is not effective at reducing the severity or preventing progression of exacerbations but will help decrease further exacerbations

schedule SABA - for several days
Definition
what is intensifying therapy?
Term
written action plan

early recognition or worsening PEF

intensification of therapy (short course systemic corticosteroids, increase ICS, schedule SABA)

removal of allergic or irritant precipitants

communication between patient and clinician about symptoms/PEF, decreased responsiveness to SABA
Definition
early treatment of asthma exacerbation
Term
large liquid volumes

breathing warm moist air

using OTC products such as antihistamines, cold remedies (need to be able to monitor the cough of an asthma patient), bronchodilators
Definition
acute asthma exacerbation treatments that should be avoided
Term
education on self-monitoring and action plan are essential

treatment:
increase SABA frequency
initiate oral corticosteroids as defined by action plan

seek medical attention when:
severe asthma exacerbation
lack of rapid, sustained improvement with therapy
further deterioration
Definition
home management of asthma exacerbation
Term
obtain brief history:
time of onset and severity of symptoms
precipitation factors
current medications and time of last dose
prior ER, hospitalization, intubation (in past year)
concurrent disease states

physical exam:
respiratory rate, heart rate
lung sounds, use of accessory muscles
identify complications (pneumothorax, pneumonia) or associated comorbidities (sinusitis)
rule out upper airway obstruction (epiglottitis, vocal cord dysfuction)

functional assessment (avoid is life threatening):
PEF - before and after bronchodilator therapy
increase risk of respiratory failure if initial PEF < 25% predicted and improves < 10% post SABA
pulse oximetry

labs:
ABG - increased risk of respiratory failure if NORMAL CO2 (may indicate respiratory failure b/c respiratory drive is typically increased in asthma exacerbations)
CBC
CXR
Definition
ER assessment of an asthma exacerbation
Term
FEV1 for PEF >/= 40%

TREATMENT

oxygen to achieve SaO2 >/= 90%

inhaled SABA by NEBULIZER OR MDI with valved holding chamber, up to 3 doses in first hour

oral systemic corticosteroids if no immediate response or if patient recently took oral systemic corticosteroids
Definition
classification and treatment of mild to moderate asthma exacerbation in hospital ED
Term
FEV1 or PEF < 40%

TREATMENT

oxygen to achieve SaO2 >/= 90%

HIGH DOSE inhaled SABA PLUS IPRATROPIUM by NEBULIZER OR MDI plus valved holding chamber, EVERY 20 MINUTES OR CONTINUOUSLY FOR 1 HOUR

oral systemic corticosteroids
Definition
classification and treatment of severe asthma exacerbation in hospital ED
Term
FEV1 or PEF < 25%

TREATMENT

intubation and mechanical ventilation with 100% oxygen

NEBULIZED SABA PLUS IPRATROPIUM

IV CORTICOSTEROIDS

consider adjunctive therapies

ADMIT TO HOSPITAL ICU
Definition
classification and treatment of impending or actual respiratory arrest in hospital ED
Term
FEV1 or PEF 40-69% predicted
physical exam: moderate symptoms

TREATMENT

inhaled SABA every 60 minutes

ORAL systemic corticosteroids

continue treatment 1-3 hours, provided there is improvement; make admit decision in < 4 hours
Definition
after 1 hour of initial treatment in hospital ED a patient with a moderate exacerbation has what FEV1 and what treatment?
Term
FEV1 or PEF < 40% predicted
physical exam: severe symptoms at rest, accessory muscle use, chest retraction
history: high-risk patient
no improvement after initial treatment

TREATMENT

oxygen

NEBULIZED SABA PLUS IPRATROPIUM hourly or continuously

ORAL systemic corticosteroids

consider adjuntive therapies
Definition
after 1 hour of initial treatment in hospital ED a patient with a severe exacerbation has what FEV1 and what treatment?
Term
initial FEV1 or PEF at 1 hour after initial treatment
Definition
strongest predictor of hospitalization in adults
Term
good response:

FEV1 or PEF >/= 70%

response sustained 60 minutes after last treatment

no distress

physical exam normal
Definition
when can a patient be discharged home after an asthma exacerbation?
Term
FEV1 or PEF 40-69%
mild to moderate symptoms

TREATMENT

ADMIT TO HOSPITAL WARD

oxygen

inhaled SABA

systemic (oral or IV) corticosteroid

consider adjunctive therapies

monitor vital signs: FEV1 or PEF, SaO2

if improvement, discharge home
Definition
patient in ED is found to have an incomplete response after asthma exacerbation treatment.
what is the classification and treatment?
Term
FEV1 or PEF < 40%
PCO2 >/= 42
physical exam: symptoms severe, drowsiness, confusion

TREATMENT

oxygen

inhaled SABA HOURLY OR CONTINUOUSLY

IV CORTICOSTEROIDS

consider adjunctive therapies

possible intubation and mechanical ventilation

if improvement, may be discharged home
Definition
patient in ED is found to have a poor response after asthma exacerbation treatment.
what is the classification and treatment?
Term
continue treatment with inhaled SABAs

continue course of systemic oral corticosteroids

continue ICS. for those not on long-term controller therapy, consider initiation of an ICS

patient education: review medications, including inhaler technique and whenever possible environmental control measures; review/initiate action plan; recommend close medical follow up

BEFORE DISCHARGE, SCHEDULE FOLLOW-UP APPOINTMENT WITH PCP AND/OR ASTHMA SPECIALIST IN 1-4 WEEKS
Definition
discharge instructions following asthma exacerbation
Term
relieve hypoxemia

recommended for treatment of significant hypoxemia or patients with FEV1 or PEF < 40% predicted

maintain SaO2 > 90%
Definition
role of oxygen
Term
RECOMMENDED FOR ALL

role: relieve airflow obstruction

route: MDI or nebulized in equivalent doses
NEBULIZER FOR LIFE-THREATENING EXACERBATIONS!

repetitive or continuous treatments given until control achieved
3 treatments spaced every 20-30 minutes or continuous nebulization (usually patients respond to this initial treatment in the ED and will be sufficient for discharge)
Definition
role of SABA
Term
RECOMMENDED FOR MOST
mild exacerbations that respond to SABA do NOT need systemic corticosteroids

role: reverse and suppress airway inflammation

route: IV/IM or PO therapy
IV for life-threatening, oral for everyone else

pulse therapy preferred:
DOSE: 1 mg/kg/day in 1-2 divided doses (DNE 60 mg/day for child or 80 mg/day for adult)
duration: until PEF reaches 70% predicted; from ER 5-10 days; from hospital 3-10 days

high dose ICS versus systemic is controversial
doubling the dose of ICS is not effective, multiple high doses of an ICS may be beneficial if given early
Definition
role of systemic corticosteroids
Term
magnesium
IV or nebulized
ADE: hypotension; MONITOR BP!
recommended for patients who remain severe after 1 hour or intensive conventional therapy
interferes with Ca transport, causes bronchodilation

heliox-driven albuterol therapy
recommended for patient who remain severe after 1 hour of intensive conventional therapy

anticholinergics:
for patients with severe exacerbation or life-threatening
not FDA approved
in ER - produces additional bronchodilation, resulting in fewer hospital admissions
at home/in hospital - no significant benefit
Definition
other therapies used to reduce risk of intubation in asthma exacerbation
Term
symptom improvement is gradual

moderate exacerbation takes 1-2 days

severe exacerbation takes >/= 3 days

continue more intensive treatment (scheduled SABA, systemic corticosteroid, increased dose of ICS) for several days
Definition
expected symptom improvement for moderate and severe asthma exacerbations
Term
1) educate on purpose of each asthma medication
2) instruct on proper inhaler technique
3) monitor asthma medication use and refill history
4) encourage physician consult regarding OTC asthma medication use
5) educate on use of peak flow meters
6) help increase understanding of action plan
Definition
pharmacist's role in asthma management
Supporting users have an ad free experience!